Evidence map›Paper›PMID 35306581›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2023

The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies.

Florian Dorn, Sahamoddin Khailaie, Marc Stoeckli, Sebastian C Binder, Tanmay Mitra, Berit Lange, Stefan Lautenbacher, Andreas Peichl, Patrizio Vanella, Timo Wollmershäuser and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Deciphering the COVID-19 Health Economic Dilemma (HED): A Scoping Review.International journal of environmental research and public health · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Florian Dorn *ifo Institute - Leibniz Institute for Economic Research at the University of Munich, Poschingerstr. 5, 81679, Munich, Germany. dorn@ifo.de.ORCID http://orcid.org/0000-0003-2476-4059
Sahamoddin Khailaie *Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Rebenring 56, 38106, Braunschweig, Germany.
Marc Stoeckli *ifo Institute - Leibniz Institute for Economic Research at the University of Munich, Poschingerstr. 5, 81679, Munich, Germany.
Sebastian C BinderDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Rebenring 56, 38106, Braunschweig, Germany.
Tanmay MitraDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Rebenring 56, 38106, Braunschweig, Germany.
Berit LangeDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 38124, Brunswick, Germany.
Stefan Lautenbacherifo Institute - Leibniz Institute for Economic Research at the University of Munich, Poschingerstr. 5, 81679, Munich, Germany.
Andreas Peichlifo Institute - Leibniz Institute for Economic Research at the University of Munich, Poschingerstr. 5, 81679, Munich, Germany.
Patrizio VanellaDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, 38124, Brunswick, Germany.
Timo Wollmershäuserifo Institute - Leibniz Institute for Economic Research at the University of Munich, Poschingerstr. 5, 81679, Munich, Germany.
Clemens Fuestifo Institute - Leibniz Institute for Economic Research at the University of Munich, Poschingerstr. 5, 81679, Munich, Germany.
Michael Meyer-HermannDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology, Helmholtz Centre for Infection Research, Rebenring 56, 38106, Braunschweig, Germany.
Ifo Institute for Economic Research · DEHelmholtz Centre for Infection Research · DEGerman Center for Infection Research · DE

Funding

bundesministerium für bildung und forschung FKZ: 01KI20102helmholtz-gemeinschaft Initiative and Networking Fundhelmholtz-gemeinschaft ZT-0027horizon 2020 101003480
6 · The paper itself

Abstract

We develop a novel approach integrating epidemiological and economic models that allows data-based simulations during a pandemic. We examine the economically optimal opening strategy that can be reconciled with the containment of a pandemic. The empirical evidence is based on data from Germany during the SARS-CoV-2 pandemic. Our empirical findings reject the view that there is necessarily a conflict between health protection and economic interests and suggest a non-linear U-shape relationship: it is in the interest of public health and the economy to balance non-pharmaceutical interventions in a manner that further reduces the incidence of infections. Our simulations suggest that a prudent strategy that leads to a reproduction number of around 0.75 is economically optimal. Too restrictive policies cause massive economic costs. Conversely, policies that are too loose lead to higher death tolls and higher economic costs in the long run. We suggest this finding as a guide for policy-makers in balancing interests of public health and the economy during a pandemic.

Indexed as

COVID-19GermanyHumansPolicyPublic HealthSARS-CoV-2COVID-19DeathsEconomyIntegrated simulationsOptimal strategyReal-time analysis

Identifiers

PMID35306581
PMCPMC8934060
OpenAlexW4221107613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.